Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs > AVAX TECHNOLOGIES INC (AVXT)

Cha-Ching.Dr. Coukos anticipates that in the future, immunotherapy

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
lefty18 Member Profile
 
Followed By 42
Posts 3,061
Boards Moderated 1
Alias Born 08/09/06
160x600 placeholder
AVAX Technologies Announces Expansion of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax®) "Business Wire" - 2/11/2014 10:17:00 AM
lefty18   Friday, 10/22/10 10:45:27 PM
Re: startingboy post# 201
Post # of 429 
Cha-Ching.

Dr. Coukos anticipates that in the future, immunotherapy in combination with surgery and chemotherapy will become a standard of care for ovarian cancer.

As it points out in the article, a big reason why the cancer vaccine has a higher than usual chance of approval by the FDA is:

no toxicity.

You can add the cancer vaccine to any cancer treatment regimen and you don't have to worry about the chemo killing the patient or making him/her too ill to stand it.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist